Aier Eye Hospital Group Co., Ltd. (SHE:300015)

Market Cap	76.86B -34.8%
Revenue (ttm)	22.72B +4.2%
Net Income	3.37B -9.0%
EPS	0.36 -9.3%
Shares Out	9.29B
PE Ratio	22.75
Forward PE	18.58
Dividend	0.20 (2.42%)
Ex-Dividend Date	Jan 15, 2026

Volume	65,866,790
Open	8.40
Previous Close	8.30
Day's Range	8.22 - 8.40
52-Week Range	8.15 - 13.95
Beta	0.44
Analysts	Buy
Price Target	14.03 (+69.65%)
Earnings Date	Jul 24, 2026

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2002
• Employees: 42,817
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300015

Financial Performance

In 2025, Aier Eye Hospital Group's revenue was 22.35 billion, an increase of 6.53% compared to the previous year's 20.98 billion. Earnings were 3.24 billion, a decrease of -8.88%.

Analyst Summary

According to 18 analysts, the average rating for 300015 stock is "Buy." The 12-month stock price target is ¥14.03, which is an increase of 69.65% from the latest price.

Price Target

¥14.03

(69.65% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error